Emergent BioSolutions
EBS
#6746
Rank
S$0.83 B
Marketcap
S$15.60
Share price
3.88%
Change (1 day)
23.08%
Change (1 year)

Emergent BioSolutions (EBS) - Net assets

Net assets on the balance sheet as of September 2025 : S$0.75 Billion

According to Emergent BioSolutions 's latest financial reports the company has S$0.75 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Emergent BioSolutions - Net assets on balance sheet (from 2004 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$0.65 B-23.47%
2023-12-31$S$0.85 B-53.9%
2022-12-31$S$1.86 B-14.61%
2021-12-31$S$2.17 B13.81%
2020-12-31$S$1.91 B30.45%
2019-12-31$S$1.46 B6.26%
2018-12-31$S$1.38 B13.18%
2017-12-31$S$1.22 B41.41%
2016-12-31$S$0.86 B-7.58%
2015-12-31$S$0.93 B27.72%
2014-12-31$S$0.73 B17.94%
2013-12-31$S$0.61 B14.63%
2012-12-31$S$0.54 B0.18%
2011-12-31$S$0.53 B12.16%
2010-12-31$S$0.48 B40.58%
2009-12-31$S$0.34 B20.06%
2008-12-31$S$0.28 B15.75%
2007-12-31$S$0.24 B16%
2006-12-31$S$0.21 B113.48%
2005-12-31$S$99.46 M165.66%
2004-12-31$S$37.43 M
2002-12-31$S$7.2 M-112.06%
2001-12-31$-S$59.79 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Merck
MRK
S$67.17 B 8,811.07%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
S$0.26 B-65.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$27.40 B 3,535.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
S$0.77 B 2.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$120.48 B 15,882.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$9.38 B 1,145.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
S$9.83 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA